(Total Views: 608)
Posted On: 04/17/2019 6:41:20 AM
Post# of 36568
Joe, care to comment?
With the 10Q/A completed and three months into the 18 month timeline, do you feel you are still on track to meet this expectation from January? Headline from the Wall Street Reporter CEO interview:
Generex Biotechnology Corp. (OTC: GNBT) Interview with CEO Joe Moscato. Joe shares an update on the continued transformation of Generex into a next-generation integrated pharmaceutical healthcare business, through strategic acquisitions. Generex's recent acquisition of medical services assets is generating over $75 million in revenues and is expect to generate over $1 billion annual revenues, as it expands to multiple states over the next 18 months.
If yes, great! If not, what would you say are your new target goals?
With the 10Q/A completed and three months into the 18 month timeline, do you feel you are still on track to meet this expectation from January? Headline from the Wall Street Reporter CEO interview:
Generex Biotechnology Corp. (OTC: GNBT) Interview with CEO Joe Moscato. Joe shares an update on the continued transformation of Generex into a next-generation integrated pharmaceutical healthcare business, through strategic acquisitions. Generex's recent acquisition of medical services assets is generating over $75 million in revenues and is expect to generate over $1 billion annual revenues, as it expands to multiple states over the next 18 months.
If yes, great! If not, what would you say are your new target goals?
(0)
(0)
